TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder that affects more than 37 million people worldwide. Current drugs for AD are only symptomatic, but do not interfere with the underlying pathogenic mechanisms of the disease. AD is characterized by the presence of ß‐amyloid (Aβ) plaques, n...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:CNS Neurosci Ther
Κύριοι συγγραφείς: Caraci, Filippo, Battaglia, Giuseppe, Bruno, Valeria, Bosco, Paolo, Carbonaro, Viviana, Giuffrida, Maria Laura, Drago, Filippo, Sortino, Maria Angela, Nicoletti, Ferdinando, Copani, Agata
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Blackwell Publishing Ltd 2009
Θέματα:
Reviews
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493850/
https://ncbi.nlm.nih.gov/pubmed/19925479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00115.x
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια